guest ::
| Home > Publications database > Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models. > print |
| Home > Publications database > Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models. > print |
| 001 | 178967 | ||
| 005 | 20240229143601.0 | ||
| 024 | 7 | _ | |a 10.3390/cancers14030849 |2 doi |
| 024 | 7 | _ | |a pmid:35159116 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC8834194 |2 pmc |
| 024 | 7 | _ | |a altmetric:123026199 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-00383 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Gatzweiler, Charlotte |0 P:(DE-He78)35c44ba0995477242f21a01ca69d6945 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models. |
| 260 | _ | _ | |a Basel |c 2022 |b MDPI |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1646126993_20517 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:B310#LA:B310# |
| 520 | _ | _ | |a The survival rate among children with relapsed tumors remains poor, due to tumor heterogeneity, lack of directly actionable tumor drivers and multidrug resistance. Novel personalized medicine approaches tailored to each tumor are urgently needed to improve cancer treatment. Current pediatric precision oncology platforms, such as the INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) study, reveal that molecular profiling of tumor tissue identifies targets associated with clinical benefit in a subgroup of patients only and should be complemented with functional drug testing. In such an approach, patient-derived tumor cells are exposed to a library of approved oncological drugs in a physiological setting, e.g., in the form of animal avatars injected with patient tumor cells. We used molecularly fully characterized tumor samples from the INFORM study to compare drug screen results of individual patient-derived cell models in functional assays: (i) patient-derived spheroid cultures within a few days after tumor dissociation; (ii) tumor cells reisolated from the corresponding mouse PDX; (iii) corresponding long-term organoid-like cultures and (iv) drug evaluation with the corresponding zebrafish PDX (zPDX) model. Each model had its advantage and complemented the others for drug hit and drug combination selection. Our results provide evidence that in vivo zPDX drug screening is a promising add-on to current functional drug screening in precision medicine platforms. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 650 | _ | 7 | |a drug screen |2 Other |
| 650 | _ | 7 | |a functional precision oncology |2 Other |
| 650 | _ | 7 | |a mPDX |2 Other |
| 650 | _ | 7 | |a patient-derived spheroid culture |2 Other |
| 650 | _ | 7 | |a small molecule inhibitors |2 Other |
| 650 | _ | 7 | |a targeted therapy |2 Other |
| 650 | _ | 7 | |a zPDX |2 Other |
| 700 | 1 | _ | |a Ridinger, Johannes |0 P:(DE-He78)53112ef656923758316e7079710bc988 |b 1 |u dkfz |
| 700 | 1 | _ | |a Herter, Sonja |0 P:(DE-He78)ea170691ed65b95f10820c4c61d6e2cd |b 2 |u dkfz |
| 700 | 1 | _ | |a Gerloff, Xenia F |0 P:(DE-He78)4302629f88822e785a2ba95b985cc952 |b 3 |u dkfz |
| 700 | 1 | _ | |a ElHarouni, Dina |0 P:(DE-He78)2bebef4e65bbcb341e31ca0999b69436 |b 4 |u dkfz |
| 700 | 1 | _ | |a Berker, Yannick |0 P:(DE-He78)b9b209c7129285852f61f807f332725a |b 5 |u dkfz |
| 700 | 1 | _ | |a Imle, Roland |0 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b |b 6 |u dkfz |
| 700 | 1 | _ | |a Schmitt, Lukas |0 P:(DE-He78)5ebf27c73a3f0b66abe1c471997cebb8 |b 7 |u dkfz |
| 700 | 1 | _ | |a Kreth, Sina |0 P:(DE-He78)21d657d65d4ad0fd8b0bbfe10fa65172 |b 8 |u dkfz |
| 700 | 1 | _ | |a Stainczyk, Sabine |0 P:(DE-He78)311fe8118b7563b455ba84e94fccb3a8 |b 9 |u dkfz |
| 700 | 1 | _ | |a Ayhan, Simay |0 P:(DE-He78)32e22d1c8416af3f2a612da9121f2c05 |b 10 |u dkfz |
| 700 | 1 | _ | |a Najafi, Sara |0 P:(DE-He78)f08873535c440e3ce033c84d5786f70f |b 11 |u dkfz |
| 700 | 1 | _ | |a Krunic, Damir |0 P:(DE-He78)2214defe87d04a849413e5eed47c415e |b 12 |u dkfz |
| 700 | 1 | _ | |a Frese, Karen |b 13 |
| 700 | 1 | _ | |a Meder, Benjamin |b 14 |
| 700 | 1 | _ | |a Reuss, David |0 P:(DE-He78)d5149ffd74f42a2fa87a086d66645aaa |b 15 |u dkfz |
| 700 | 1 | _ | |a Fiesel, Petra |0 P:(DE-He78)8de7015af76bd61fb0bc13bb3facb1df |b 16 |u dkfz |
| 700 | 1 | _ | |a Schramm, Kathrin |0 P:(DE-He78)2f592d9d8339bee07cca3956b7472b61 |b 17 |u dkfz |
| 700 | 1 | _ | |a Blattner-Johnson, Mirjam |0 P:(DE-He78)261d2b84aded878003e6e35d18113831 |b 18 |u dkfz |
| 700 | 1 | _ | |a Jones, David T W |0 P:(DE-He78)551bb92841f634070997aa168d818492 |b 19 |u dkfz |
| 700 | 1 | _ | |a Banito, Ana |0 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8 |b 20 |u dkfz |
| 700 | 1 | _ | |a Westermann, Frank |0 P:(DE-He78)91f32735ee876c579d63c05a7f4778dd |b 21 |u dkfz |
| 700 | 1 | _ | |a Oppermann, Sina |0 P:(DE-He78)55dfd5b374ab9bccdb49e06e91345571 |b 22 |u dkfz |
| 700 | 1 | _ | |a Milde, Till |0 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f |b 23 |u dkfz |
| 700 | 1 | _ | |a Peterziel, Heike |0 P:(DE-He78)2727b5cb63b52d0137d4f4e8f110ee7e |b 24 |u dkfz |
| 700 | 1 | _ | |a Witt, Olaf |0 P:(DE-He78)143af26de9d57bf624771616318aaf7c |b 25 |u dkfz |
| 700 | 1 | _ | |a Oehme, Ina |0 P:(DE-He78)908367a659dea9e28dac34592b3c46e5 |b 26 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.3390/cancers14030849 |g Vol. 14, no. 3, p. 849 - |0 PERI:(DE-600)2527080-1 |n 3 |p 849 |t Cancers |v 14 |y 2022 |x 2072-6694 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:178967 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)35c44ba0995477242f21a01ca69d6945 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)53112ef656923758316e7079710bc988 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)ea170691ed65b95f10820c4c61d6e2cd |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)4302629f88822e785a2ba95b985cc952 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)2bebef4e65bbcb341e31ca0999b69436 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)b9b209c7129285852f61f807f332725a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)5ebf27c73a3f0b66abe1c471997cebb8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)21d657d65d4ad0fd8b0bbfe10fa65172 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)311fe8118b7563b455ba84e94fccb3a8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)32e22d1c8416af3f2a612da9121f2c05 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)f08873535c440e3ce033c84d5786f70f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)2214defe87d04a849413e5eed47c415e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)d5149ffd74f42a2fa87a086d66645aaa |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)8de7015af76bd61fb0bc13bb3facb1df |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)2f592d9d8339bee07cca3956b7472b61 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)261d2b84aded878003e6e35d18113831 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)551bb92841f634070997aa168d818492 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)91f32735ee876c579d63c05a7f4778dd |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)55dfd5b374ab9bccdb49e06e91345571 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)2727b5cb63b52d0137d4f4e8f110ee7e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)143af26de9d57bf624771616318aaf7c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)908367a659dea9e28dac34592b3c46e5 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-05-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-05-04 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-05-04 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-05-04 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCERS : 2021 |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2022-01-24T07:56:58Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2022-01-24T07:56:58Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2022-01-24T07:56:58Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-30 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-30 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-30 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CANCERS : 2021 |d 2022-11-30 |
| 920 | 2 | _ | |0 I:(DE-He78)B310-20160331 |k B310 |l KKE Pädiatrische Onkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B310-20160331 |k B310 |l KKE Pädiatrische Onkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B240-20160331 |k B240 |l B240 Bioinformatik und Omics Data Analytics |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)B380-20160331 |k B380 |l NWG Weichteil-Sarkome |x 4 |
| 920 | 1 | _ | |0 I:(DE-He78)B087-20160331 |k B087 |l B087 Neuroblastom Genomik |x 5 |
| 920 | 1 | _ | |0 I:(DE-He78)W210-20160331 |k W210 |l Lichtmikroskopie |x 6 |
| 920 | 1 | _ | |0 I:(DE-He78)B300-20160331 |k B300 |l KKE Neuropathologie |x 7 |
| 920 | 1 | _ | |0 I:(DE-He78)B360-20160331 |k B360 |l Pediatric Glioma |x 8 |
| 920 | 0 | _ | |0 I:(DE-He78)B310-20160331 |k B310 |l KKE Pädiatrische Onkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B310-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B240-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B380-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B087-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W210-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B300-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B360-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|